Identity
- Trade Name
- CD16 (SP175) Rabbit Monoclonal Antibody FDA UDI
- Generic Name
- CD16 cell marker IVD, antibody FDA UDI
- Model / Reference
- 116R-14 FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00841683123699 FDA UDI
- FDA Product Code
- NJT FDA UDI
- GMDN Term
- CD16 cell marker IVD, antibody FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.1860 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: CD16 cell marker IVD, antibody
CD16 (SP175) Rabbit Monoclonal Antibody by Cell Marque Corporation — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as CD16 cell marker IVD, antibody.
- CD16 (RBT-CD16) — BIO SB, INC. · Class I
- Rabbit Monoclonal Anti-Human CD16, EP364 — EPITOMICS, INC. · Class I
- Human CD16 FITC Conjugate — LIFE TECHNOLOGIES LIMITED · Class I
- Rabbit Monoclonal Anti-Human CD16, EP364 — EPITOMICS, INC. · Class I
- ANTI-CD16 — Biogenex Laboratories, Inc. · Class I
- Tinto CD16 (RBT-CD16) — BIO SB, INC. · Class I
- Human CD16 Pacific Blue™ Conjugate — LIFE TECHNOLOGIES LIMITED · Class I
- CD16 (RBT-CD16) — BIO SB, INC. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Cell Marque Corporation
Sources (1)
- FDA UDI 18806d7e-8395-4c57-b2f2-30d662b9bc77 33 fields · synced May 30, 2026